Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Thyrocare"

30 News Found

Thyrocare opens regional processing lab in Ahmedabad
News | June 06, 2022

Thyrocare opens regional processing lab in Ahmedabad

New Regional Processing Lab will serve Ahmedabad and the state of Gujarat


Thyrocare unveils new brand identity
News | June 01, 2022

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services


Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day
Clinical Trials | May 25, 2022

Thyrocare launches its Regional Processing Lab in Nagpur on World Thyroid Day

The new advanced regional processing lab will serve Nagpur city and the Vidarbha region


Rahul Guha to join Thyrocare Technologies as MD & CEO
People | February 07, 2022

Rahul Guha to join Thyrocare Technologies as MD & CEO

Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Vimta Labs reports 10% YoY growth in Q3 FY26, PAT margins hold at 17.5%
News | January 30, 2026

Vimta Labs reports 10% YoY growth in Q3 FY26, PAT margins hold at 17.5%

The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year


Vimta Labs reports Q2 FY25 PAT at Rs. 17 Cr
News | November 10, 2024

Vimta Labs reports Q2 FY25 PAT at Rs. 17 Cr

Q2 FY25 Total Income was at Rs. 85.4 crore


Build a sustainable healthcare and lifesciences industry, say Experts
Healthcare | March 11, 2023

Build a sustainable healthcare and lifesciences industry, say Experts

Time to combine innovation, access and technology to deliver positive patient outcomes


Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners
Opinion | September 22, 2022

Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners

Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.


HaystackAnalytics sees alarming rise in TB cases
Healthcare | March 24, 2022

HaystackAnalytics sees alarming rise in TB cases

A staggering 65% of the TB cases in India are in the 15-45 age group